Literature DB >> 1516011

Paraneoplastic myelopathy at diagnosis in a patient with pathologic stage 1A Hodgkin disease.

M Hughes1, V Ahern, R Kefford, J Boyages.   

Abstract

The case of a patient with pathologic Stage 1A Hodgkin disease is reported in whom subacute paraneoplastic myelopathy developed before treatment. Myelography, computed tomography, magnetic resonance imaging, and lumbar puncture examination showed no evidence of central nervous system involvement. The patient was treated with combination chemotherapy (to avoid spinal cord exposure to radiation) without neurologic improvement. The patient's neurologic condition responded well to intrathecal dexamethasone.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1516011     DOI: 10.1002/1097-0142(19920915)70:6<1598::aid-cncr2820700625>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

Review 1.  A review of the therapy of paraneoplastic neurologic syndromes.

Authors:  A Das; F H Hochberg; S McNelis
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Subacute paraneoplastic radiculomyelitis associated with Hodgkin lymphoma.

Authors:  F Piéret; M Gille; J Lemmens; J Delbecq; A Depré
Journal:  J Neurol       Date:  1996-06       Impact factor: 4.849

Review 3.  Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas.

Authors:  Francesc Graus; Helena Ariño; Josep Dalmau
Journal:  Blood       Date:  2014-04-04       Impact factor: 22.113

4.  Paraneoplastic Necrotizing Myelopathy in a Patient With Newly Diagnosed Diffuse Large B Cell Lymphoma.

Authors:  Chau Hung Lee; Lavina Bharwani; Troy Sullivan
Journal:  World J Oncol       Date:  2011-08-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.